PEA
GILD icon

Park Edge Advisors’s Gilead Sciences GILD Stock Holding History

Park Edge Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
+10,590
New +$1.4M 0.28% 68

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Park Edge Advisors's GILD Position: Q2 2026 in Review

Park Edge Advisors opened a new position in Gilead Sciences (GILD) in Q2 2026: 10,590 shares worth $1.34M. The stake represents 0.28% of the portfolio and ranks #68 among its holdings.

361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Park Edge Advisors held 10,590 shares of Gilead Sciences worth $1.34M as of Q2 2026.
  • Gilead Sciences was a new Park Edge Advisors position in Q2 2026.
  • Gilead Sciences made up 0.28% of Park Edge Advisors's portfolio in Q2 2026, its #68 holding.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Park Edge Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.